The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes
Abstract
Purpose: Many studies have examined the effect of caffeine on exercise performance, but findings have not always been consistent. The objective of this study was to determine whether variation in the CYP1A2 gene, which affects caffeine metabolism, modifies the ergogenic effects of caffeine in a 10-km cycling time trial. Methods: Competitive male athletes ( n = 101; age = 25 ± 4 yr) completed the time trial under three conditions: 0, 2, or 4 mg of caffeine per kilogram body mass, using a split-plot randomized, double-blinded, placebo-controlled design. DNA was isolated from saliva and genotyped for the −163A > C polymorphism in the CYP1A2 gene (rs762551). Results: Overall, 4 mg·kg −1 caffeine decreased cycling time by 3% (mean ± SEM) versus placebo (17.6 ± 0.1 vs 18.1 ± 0.1 min, P = 0.01). However, a significant ( P <0.0001) caffeine–gene interaction was observed. Among those with the AA genotype, cycling time decreased by 4.8% at 2 mg·kg −1 (17.0 ± 0.3 vs 17.8 ± 0.4 min, P = 0.0005) and by 6.8% at 4 mg·kg −1 (16.6 ± 0.3 vs 17.8 ± 0.4 min, P < 0.0001). In those with the CC genotype, 4 mg·kg −1 increased cycling time by 13.7% versus placebo (20.8 ± 0.8 vs 18.3 ± 0.5 min, P = 0.04). No effects were observed among those with the AC genotype. Conclusion: Our findings show that both 2 and 4 mg·kg −1 caffeine improve 10-km cycling time, but only in those with the AA genotype. Caffeine had no effect in those with the AC genotype and diminished performance at 4 mg·kg −1 in those with the CC genotype. CYP1A2 genotype should be considered when deciding whether an athlete should use caffeine for enhancing endurance performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals classified as CYP1A2 slow metabolizers may experience more prolonged vasoconstriction and delayed hypertensive responses.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [87]
In the citing paper
“some of the caffeine-induced stimulant effects are of smaller magnitude in women than in men [297].”
From International society of sports nutrition position stand: nutritional concerns of the female athlete (2023) · cites this paper as [297]
Citations
Cites
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Doherty, M., & Smith, P. M. (2005) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2005.00445.x · Cited by 513
Coffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490 · cited 2×
“Individuals with the AC or CC genotype (slow metabolizers) have an elevated risk of myocardial infarction (24), hypertension (25), and prediabetes (26) with increasing caffeinated coffee consumption, whereas those with the AA genotype show no such risk.”
BackgroundResultPerformance and metabolic responses to a high caffeine dose during prolonged exercise
Graham, T. E., & Spriet, L. L. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.6.2292 · Cited by 338
Effect of Caffeine on Sport-Specific Endurance Performance: A Systematic Review
Ganio, M. S., Klau, J. F., Casa, D. J., Armstrong, L. E., & Maresh, C. M. (2009) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31818b979a · Cited by 310
Ghotbi, R., Christensen, M., Roh, H.-K., Ingelman-Sundberg, M., Aklillu, E., & Bertilsson, L. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0288-2 · Cited by 264
Effects of Caffeine Ingestion on Exercise Testing: A Meta-Analysis
Doherty, M., & Smith, P. M. (2004) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.14.6.626 · Cited by 263
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension
Palatini, P., Ceolotto, G., Ragazzo, F., Dorigatti, F., Saladini, F., Papparella, I., Mos, L., Zanata, G., & Santonastaso, M. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832ba850 · Cited by 230
Placebo Effects of Caffeine on Cycling Performance
BEEDIE, C. J., STUART, E. M., COLEMAN, D. A., & FOAD, A. J. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233805.56315.a9 · Cited by 209
Placebo in sports nutrition: a proof‐of‐principle study involving caffeine supplementation
Saunders, B., de Oliveira, L. F., da Silva, R. P., de Salles Painelli, V., Gonçalves, L. S., Yamaguchi, G., Mutti, T., Maciel, E., Roschel, H., Artioli, G. G., et al. (2017) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.12793 · Cited by 195
Cited by
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
Self-citationSouthward, K., Rutherfurd-Markwick, K. J., & Ali, A. (2018) · Sports Medicine · doi:10.1007/s40279-018-0939-8 · Cited by 254
“[45, 66, 71, 72], 55 min [60], 90 min [53, 57, 59, 61, 65] and 120–150 min [55] prior to exercise.”
BackgroundSalinero, J. J., Lara, B., & Del Coso, J. (2019) · Research in Sports Medicine · doi:10.1080/15438627.2018.1552146 · Cited by 176
Sport Nutrigenomics: Personalized Nutrition for Athletic Performance
Guest, N. S., Horne, J., Vanderhout, S. M., & El-Sohemy, A. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00008 · Cited by 174
“Individuals with the CYP1A2 AC or CC genotype experience no effect or impaired performance, respectively, from caffeine use (19). based on their DNA could yield a competitive edge.”
BackgroundInfluentialSelf-citationCaffeine and Exercise: What Next?
Pickering, C., & Grgic, J. (2019) · Sports Medicine · doi:10.1007/s40279-019-01101-0 · Cited by 158
Metadata
- Authors
- GUEST, N., COREY, P., VESCOVI, J., & EL-SOHEMY, A.
- Affiliations
- University of Toronto (CA)
- Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, CANADA;
- Venue
- Medicine & Science in Sports & Exercise
- Published
- 2018-08
- Volume
- 50
- Issue
- 8
- Pages
- 1570-1578
- ISSN
- 0195-9131 (ISSN-L)
- 1530-0315
- OpenAlex
- W2791466980
- Cited by
- 231
- References
- 40
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 41 · 2023: 21 · 2022: 26 · 2021: 19 · 2020: 37 · 2019: 23 · 2018: 19
- FWCI
- 15.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicine & Science in Sports & Exercise (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- caffeine, caffeine metabolism, endurance performance, gene-diet interaction, athletes, ergogenic aids, caffeine dose-response
- MeSH terms
- Adult, Caffeine, Double-Blind Method, Exercise Test, Physical Exertion, Genotype, Heart Rate, Humans, Male, Perception, Physical Endurance, Cytochrome P-450 CYP1A2, Polymorphism, Single Nucleotide, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes. https://app.cochat.ai/papers/10.1249/mss.0000000000001596
- The paper
- GUEST, N., COREY, P., VESCOVI, J., & EL-SOHEMY, A. (2018). Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0000000000001596
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.